Adagio Medica announced that the company’s chief business officer, Deborah Kaster’s, responsibilities have been expanded to include the role of CFO, effective September 5. Kaster succeeds Dan George, who served as the company’s interim CFO since April. In this enhanced position as CFO and CBO, Kaster will continue to oversee business development, corporate strategy and investor relations while assuming responsibility for the company’s financial operations, including accounting, treasury, and financial planning. Kaster will continue to report to Todd Usen, CEO of Adagio.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ADGM:
